Experience of using subcutaneous levetiracetam in palliative patients

Experience of using subcutaneous levetiracetam in palliative patients

Bibliographic Details
Main Authors:	G. Más-Sesé, D. Martín-Bautista, A. Navarro-Catalá
Format:	Article
Language:	English
Published:	Elsevier España 2021-07-01
Series:	Neurología (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2173580821000511

Similar Items

Subcutaneous Levetiracetam Application Sustains Therapeutic Drug Levels
Published: (2021-05-01)

Subcutaneous drug administration in palliative care
by: Carmen Matoses Chirivella, et al.
Published: (2015-01-01)

LEVETIRACETAM IN TREATMENT OF EPILEPSY, OWN EXPERIENCE OF APPLICATION IN ADULT PATIENTS
by: G. G. Toropina
Published: (2017-05-01)

Levetiracetam-induced pancytopenia
by: Talal Alzahrani, et al.
Published: (2015-01-01)

Hallucination in a Seizure Patient Using Levetiracetam: A Case Report
by: D. R. Shakya, et al.
Published: (2012-01-01)

Experience and pharmacokinetics of Levetiracetam in Korean neonates with neonatal seizures
by: Jae Won Shin, et al.
Published: (2017-02-01)

Continuous subcutaneous infusion for pain control in dying patients: experiences from a tertiary palliative care center
by: Per Fürst, et al.
Published: (2020-11-01)

Levetiracetam use in the critical care setting
by: Jerzy P Szaflarski, et al.
Published: (2013-08-01)

Levetiracetam in Partial Seizures
by: J Gordon Millichap
Published: (2002-06-01)

Levetiracetam in the treatment of epilepsy
by: Bassel Abou-Khalil
Published: (2008-06-01)

Levetiracetam induced rhabdomyolysis
by: Anthony C. Torres, et al.
Published: (2021-01-01)

How about Levetiracetam in Glioblastoma? An Institutional Experience and Meta-Analysis
by: Ramazan Jabbarli, et al.
Published: (2021-07-01)

Pharmacokinetics of levetiracetam in neonates with seizures
by: Merhar, Stephanie L., M.D.
Published: (2011)

Complications of the subcutaneous route in the infusion of medications and solutions in palliative care
by: Natália de Almeida Barbosa Guedes, et al.
Published: (2019-09-01)

Levetiracetam for Pediatric Posttraumatic Seizure Prophylaxis
by: Dragos A. Nita, et al.
Published: (2016-07-01)

Clonidine and Levetiracetam for Tics Compared
by: J Gordon Millichap
Published: (2009-06-01)

Levetiracetam in Landau-Kleffner Syndrome
by: J Gordon Millichap
Published: (2003-11-01)

Effect of Levetiracetam on Motor Learning
by: J Gordon Millichap
Published: (2003-01-01)

Clinical Pharmacology and Pharmacokinetics of Levetiracetam
by: Chanin Clark Wright, et al.
Published: (2013-12-01)

Essential tremor responsive to levetiracetam
by: Abdullah Yılgör, et al.
Published: (2012-03-01)

Neurobehavioral Effects of Levetiracetam in Patients with Traumatic Brain Injury
by: Jared F Benge, et al.
Published: (2013-12-01)

Levetiracetam efficacy in patients with Lennox-Gastaut syndrome. Presentation of a case
by: A. Díaz Negrillo, et al.
Published: (2011-01-01)

Levetiracetam as an alternative therapy for Tourette syndrome
by: MA Mart&iacute;nez-Granero, et al.
Published: (2010-05-01)

Assessment of the biomarkers of hepatotoxicity following carbamazepine, levetiracetam, and carbamazepine-levetiracetam adjunctive treatment in male Wistar rats
by: Opeyemi Samson Osuntokun, et al.
Published: (2021-01-01)

Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
by: Tae Hoon Roh, et al.
Published: (2020-07-01)

Efficacy of levetiracetam in treatment of childhood stuttering
by: Mohammadreza Ghazavi, et al.
Published: (2020-01-01)

Facial Dysmorphism: An Unreported Teratogenicity with Levetiracetam
by: Jyotsana Gupta, et al.
Published: (2017-01-01)

Efficacy and Tolerability of Intravenous Levetiracetam in Children
by: Jose eAceves, et al.
Published: (2013-08-01)

Levetiracetam for the Treatment of Refractor Neonatal Seizures
by: Esengül KELEŞ, et al.
Published: (2012-01-01)

Monotherapy for partial epilepsy: focus on levetiracetam
by: Antonio Gambardella, et al.
Published: (2008-03-01)

Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam
by: Jae Wook Cho, et al.
Published: (2014-04-01)

Intravenous levetiracetam in critically ill children
by: Faruk Incecik, et al.
Published: (2016-01-01)

Efficacy of levetiracetam in refractory childhood epilepsy
by: Keon Su Lee, et al.
Published: (2010-04-01)

Delayed Recognition of Levetiracetam-induced Pancytopenia
by: Mohammad Ammad Ud Din, et al.
Published: (2021-03-01)

Clinical outcomes of intravenous levetiracetam treatment in patients with renal impairment
by: Anyamanee Lapmag, et al.
Published: (2018-09-01)

Effects of Levetiracetam Compared to Valproate on Cognitive Functions of Patients with Epilepsy
by: El Sabaa RM, et al.
Published: (2020-08-01)

The role of Intravenous Levetiracetam in Treatment of Seizures in Brain Tumor Patients
by: Ekokobe eFonkem, et al.
Published: (2013-10-01)

Restless Legs Syndrome in Patients with Epilepsy Under Levetiracetam Monotherapy
by: Gülnihal Kutlu, et al.
Published: (2018-03-01)

Review: Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited
by: Rainer Surges, et al.
Published: (2008-07-01)

Genetic risk factors for behavioral adverse reactions in epileptic patients taking levetiracetam
by: A. A. Usoltseva, et al.
Published: (2019-12-01)